Phase 3 study met all co-primary and secondary endpoints and achieved statistically significant results.
Umbilical cords of children whose mothers used selective serotonin reuptake inhibitors during pregnancy may be longer than umbilical cords of other newborn children, shows a new study.
More than 4,000 type 2 diabetes patients took part in this placebo-controlled global study over the course of three years.
Electronic cigarettes have sickened rising numbers of young children, a study of U.S. poison center calls has found. Most cases involve swallowing liquid nicotine.
New research suggests that synthetic peptides called minihepcidins may potentially treat two serious genetic blood diseases in children and adults.
The test can be stored at room temperature and read with a simple electronic reader.
The committee is made up of a team of Valeant employees including doctors, scientists and other executives.
The draft guidance recommends the drugs, which are not licensed for everyone who has high cholesterol levels, only if they are provided at the discounted price agreed with the companies.
Patients with the heart rhythm disorder atrial fibrillation (AF) who were treated long term with the blood thinner, warfarin, may have higher rates of dementia, according to a recent study of more than 10,000 patients.
Allergan is the first company to launch a generic version of of this drug to customers in the U.S.
In recent years, it has become clear that the impact of epigenetics is more common and complex than previously suspected, underscoring the need to conduct in-depth studies of these mechanisms.
The swift response came hours after Paris-based Sanofi, France's biggest drugmaker, threatened Medivation's board members with possible removal if they won't discuss a deal.
More than 15 million Americans have prescriptions for so-called proton pump inhibitors (PPIs), which decrease gastric acid production and generally have been considered safe.
The new grant will enable Disney and his team to further investigate the manipulation of microRNAs.
The immune system appears to hamper an investigational vaccine from inducing antibodies that protect against HIV infection.